Form 4 for ATOS ATOSSA THERAPEUTICS, INC.
Accepted 2025-05-22 00:00:00 ET · period of report 2025-05-21 · accession 0000950170-25-076523 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-22 | 2025-05-21 | ATOS | QUAY STEVEN C | Pres, CEO, Dir | P - Purchase | $0.88 | +11.2K | 13.9K | +423% | +$9,890 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-21 | P | A | 11,239 | $0.88 | 13,898 | D | — | — | (F1) The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $0.8794 to $0.9100. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of share purchased at each separate price. |